Achillion Pharmaceuticals (ACHN) Reports Positive Phase 2a Clinical Results for Hepatitis C Treatment
Achillion Pharmaceuticals Inc., an innovative pharmaceutical focused on solutions against infectious disease including hepatitis C and resistant bacterial infections, today…